Carlos Campoy
Director/Board Member at ZYMEWORKS INC.
Net worth: - $ as of 2024-04-29
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Ken Galbraith | M | 61 |
Zymeworks BC, Inc.
 Zymeworks BC, Inc. BiotechnologyHealth Technology Zymeworks BC, Inc. is a clinical-stage biopharmaceutical company engaged in the discovery, development, and commercialization of biotherapeutics. Its product, ZW25 and ZW49, are a bispecific antibody that cans two non-overlapping epitopes. The company was founded by Anthony Fejes, J. Haig deB Farris, Nick Bedford, Ali Tehrani and Andrew S. Wright on September 8, 2003 and is headquartered in Vancouver, Canada. | 16 years |
| Christopher Astle | M | 45 |
Zymeworks BC, Inc.
Zymeworks BC, Inc. BiotechnologyHealth Technology Zymeworks BC, Inc. is a clinical-stage biopharmaceutical company engaged in the discovery, development, and commercialization of biotherapeutics. Its product, ZW25 and ZW49, are a bispecific antibody that cans two non-overlapping epitopes. The company was founded by Anthony Fejes, J. Haig deB Farris, Nick Bedford, Ali Tehrani and Andrew S. Wright on September 8, 2003 and is headquartered in Vancouver, Canada. | 5 years |
| Susan Mahony | M | 59 |
Zymeworks BC, Inc.
Zymeworks BC, Inc. BiotechnologyHealth Technology Zymeworks BC, Inc. is a clinical-stage biopharmaceutical company engaged in the discovery, development, and commercialization of biotherapeutics. Its product, ZW25 and ZW49, are a bispecific antibody that cans two non-overlapping epitopes. The company was founded by Anthony Fejes, J. Haig deB Farris, Nick Bedford, Ali Tehrani and Andrew S. Wright on September 8, 2003 and is headquartered in Vancouver, Canada. | 5 years |
| Kenneth Hillan | M | 63 |
Zymeworks BC, Inc.
Zymeworks BC, Inc. BiotechnologyHealth Technology Zymeworks BC, Inc. is a clinical-stage biopharmaceutical company engaged in the discovery, development, and commercialization of biotherapeutics. Its product, ZW25 and ZW49, are a bispecific antibody that cans two non-overlapping epitopes. The company was founded by Anthony Fejes, J. Haig deB Farris, Nick Bedford, Ali Tehrani and Andrew S. Wright on September 8, 2003 and is headquartered in Vancouver, Canada. | 7 years |
| Daniel Dex | M | - |
Zymeworks BC, Inc.
Zymeworks BC, Inc. BiotechnologyHealth Technology Zymeworks BC, Inc. is a clinical-stage biopharmaceutical company engaged in the discovery, development, and commercialization of biotherapeutics. Its product, ZW25 and ZW49, are a bispecific antibody that cans two non-overlapping epitopes. The company was founded by Anthony Fejes, J. Haig deB Farris, Nick Bedford, Ali Tehrani and Andrew S. Wright on September 8, 2003 and is headquartered in Vancouver, Canada. | 7 years |
| Hollings Renton | M | 77 |
Zymeworks BC, Inc.
Zymeworks BC, Inc. BiotechnologyHealth Technology Zymeworks BC, Inc. is a clinical-stage biopharmaceutical company engaged in the discovery, development, and commercialization of biotherapeutics. Its product, ZW25 and ZW49, are a bispecific antibody that cans two non-overlapping epitopes. The company was founded by Anthony Fejes, J. Haig deB Farris, Nick Bedford, Ali Tehrani and Andrew S. Wright on September 8, 2003 and is headquartered in Vancouver, Canada. | 7 years |
| Troy Cox | M | 60 |
Zymeworks BC, Inc.
Zymeworks BC, Inc. BiotechnologyHealth Technology Zymeworks BC, Inc. is a clinical-stage biopharmaceutical company engaged in the discovery, development, and commercialization of biotherapeutics. Its product, ZW25 and ZW49, are a bispecific antibody that cans two non-overlapping epitopes. The company was founded by Anthony Fejes, J. Haig deB Farris, Nick Bedford, Ali Tehrani and Andrew S. Wright on September 8, 2003 and is headquartered in Vancouver, Canada. | 5 years |
| Kelvin Neu | M | 50 |
Zymeworks BC, Inc.
Zymeworks BC, Inc. BiotechnologyHealth Technology Zymeworks BC, Inc. is a clinical-stage biopharmaceutical company engaged in the discovery, development, and commercialization of biotherapeutics. Its product, ZW25 and ZW49, are a bispecific antibody that cans two non-overlapping epitopes. The company was founded by Anthony Fejes, J. Haig deB Farris, Nick Bedford, Ali Tehrani and Andrew S. Wright on September 8, 2003 and is headquartered in Vancouver, Canada. | 4 years |
| Chris Ogden | M | 40 | 3 years | |
| Halley Gilbert | F | 54 | 4 years | |
| Jennifer Kaufman-Shaw | M | 74 |
Zymeworks BC, Inc.
Zymeworks BC, Inc. BiotechnologyHealth Technology Zymeworks BC, Inc. is a clinical-stage biopharmaceutical company engaged in the discovery, development, and commercialization of biotherapeutics. Its product, ZW25 and ZW49, are a bispecific antibody that cans two non-overlapping epitopes. The company was founded by Anthony Fejes, J. Haig deB Farris, Nick Bedford, Ali Tehrani and Andrew S. Wright on September 8, 2003 and is headquartered in Vancouver, Canada. | 10 years |
| Mark Hollywood | M | 55 |
Zymeworks BC, Inc.
Zymeworks BC, Inc. BiotechnologyHealth Technology Zymeworks BC, Inc. is a clinical-stage biopharmaceutical company engaged in the discovery, development, and commercialization of biotherapeutics. Its product, ZW25 and ZW49, are a bispecific antibody that cans two non-overlapping epitopes. The company was founded by Anthony Fejes, J. Haig deB Farris, Nick Bedford, Ali Tehrani and Andrew S. Wright on September 8, 2003 and is headquartered in Vancouver, Canada. | 5 years |
| Paul Moore | M | 58 |
Zymeworks BC, Inc.
Zymeworks BC, Inc. BiotechnologyHealth Technology Zymeworks BC, Inc. is a clinical-stage biopharmaceutical company engaged in the discovery, development, and commercialization of biotherapeutics. Its product, ZW25 and ZW49, are a bispecific antibody that cans two non-overlapping epitopes. The company was founded by Anthony Fejes, J. Haig deB Farris, Nick Bedford, Ali Tehrani and Andrew S. Wright on September 8, 2003 and is headquartered in Vancouver, Canada. | 2 years |
| Derek Miller | M | 54 | 1 years | |
| Alan Ashworth | M | 63 | 3 years | |
| Jack Spinks | M | - |
Zymeworks BC, Inc.
Zymeworks BC, Inc. BiotechnologyHealth Technology Zymeworks BC, Inc. is a clinical-stage biopharmaceutical company engaged in the discovery, development, and commercialization of biotherapeutics. Its product, ZW25 and ZW49, are a bispecific antibody that cans two non-overlapping epitopes. The company was founded by Anthony Fejes, J. Haig deB Farris, Nick Bedford, Ali Tehrani and Andrew S. Wright on September 8, 2003 and is headquartered in Vancouver, Canada. | 1 years |
| Diana Papove | F | - |
Zymeworks BC, Inc.
Zymeworks BC, Inc. BiotechnologyHealth Technology Zymeworks BC, Inc. is a clinical-stage biopharmaceutical company engaged in the discovery, development, and commercialization of biotherapeutics. Its product, ZW25 and ZW49, are a bispecific antibody that cans two non-overlapping epitopes. The company was founded by Anthony Fejes, J. Haig deB Farris, Nick Bedford, Ali Tehrani and Andrew S. Wright on September 8, 2003 and is headquartered in Vancouver, Canada. | 4 years |
| Mani Mohindru | M | 52 | 4 years | |
| Catherine Graham | F | - | 6 years | |
| Lucas Donigian | M | - | 4 years | |
| Bijal Desai | F | - | - | |
| Derek Miller | M | - |
Zymeworks BC, Inc.
Zymeworks BC, Inc. BiotechnologyHealth Technology Zymeworks BC, Inc. is a clinical-stage biopharmaceutical company engaged in the discovery, development, and commercialization of biotherapeutics. Its product, ZW25 and ZW49, are a bispecific antibody that cans two non-overlapping epitopes. The company was founded by Anthony Fejes, J. Haig deB Farris, Nick Bedford, Ali Tehrani and Andrew S. Wright on September 8, 2003 and is headquartered in Vancouver, Canada. | - |
| Jeffrey Landau | M | 46 | 3 years | |
| Kaycia Wilde | M | - |
Zymeworks BC, Inc.
Zymeworks BC, Inc. BiotechnologyHealth Technology Zymeworks BC, Inc. is a clinical-stage biopharmaceutical company engaged in the discovery, development, and commercialization of biotherapeutics. Its product, ZW25 and ZW49, are a bispecific antibody that cans two non-overlapping epitopes. The company was founded by Anthony Fejes, J. Haig deB Farris, Nick Bedford, Ali Tehrani and Andrew S. Wright on September 8, 2003 and is headquartered in Vancouver, Canada. | 3 years |
| Nancy E. Davidson | M | - | 1 years | |
| Bruce Hart | M | 60 |
Zymeworks BC, Inc.
Zymeworks BC, Inc. BiotechnologyHealth Technology Zymeworks BC, Inc. is a clinical-stage biopharmaceutical company engaged in the discovery, development, and commercialization of biotherapeutics. Its product, ZW25 and ZW49, are a bispecific antibody that cans two non-overlapping epitopes. The company was founded by Anthony Fejes, J. Haig deB Farris, Nick Bedford, Ali Tehrani and Andrew S. Wright on September 8, 2003 and is headquartered in Vancouver, Canada. | 5 years |
| Scott Platshon | M | 32 | - | |
| Alessandra Cesano | M | 63 | - | |
| Jeffrey T. L. Smith | M | 64 | 1 years | |
| Laura O’Connor | F | - | 4 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Brenton Saunders | M | 56 | 6 years | |
| Scott Giacobello | M | 54 | 7 years | |
| Amy Peterson | M | 57 | 3 years | |
| David Adam Buchen | M | 59 | 1 years | |
| Robert Azelby | M | 56 | 1 years | |
| Neil Klompas | M | 52 | 16 years | |
| Frederick Gluck | M | 88 | 12 years | |
| Andrew L. Turner | M | 77 | 2 years | |
| Chau Cheng | M | - | 2 years | |
| C. Nicholson | M | 68 | 6 years | |
| Paul Carter | M | 63 | 4 years | |
| Christopher Coughlin | M | 71 | 6 years | |
| John Latham | M | 64 | 15 years | |
| Ambrose Bailey | M | 60 | 6 years | |
| John Kelly | M | 57 | 6 years | |
| Peter John McDonnell | M | 66 | 5 years | |
| Jonathon Kellerman | M | - | 6 years | |
| Nesli Basgoz | M | 66 | 6 years | |
| Larry K. Benedict | M | 63 | 11 years | |
| Sigurdur Olafsson | M | 55 | 4 years | |
| John Scarlett | M | 73 | 6 years | |
| Lota Zoth | F | 64 | 7 years | |
| John A. King | M | 74 | 2 years | |
| Michael R. Gallagher | M | 77 | 2 years | |
| Robert Todd Joyce | M | 66 | 1 years | |
| Deepa Pakianathan | M | 59 | 6 years | |
| Hafrun Fridriksdottir | M | 62 | 14 years | |
| Clay Siegall | M | 63 | 14 years | |
| Alan Montgomery | M | 70 | 9 years | |
| Jirí Michal | M | 71 | 2 years | |
| Nick Galli | M | - | 2 years | |
| David Melnick | M | 72 | - | |
| Sue-Jean Lin | F | 65 | 26 years | |
| Christopher Keenan | M | - | 2 years | |
| Matthew Moore | M | 51 | 5 years | |
| Natalie Sacks | M | 59 | 6 years | |
| Megan Schoeps | F | 40 | 2 years | |
| Paul Streck | M | 60 | - | |
| Nori Ebersole | F | 60 | 18 years | |
| Yao Lee | M | 54 | 4 years | |
| Nadia Dac | F | 54 | 1 years | |
| Ian A. Critchley | M | - | 3 years | |
| Daniel Motto | M | - | 6 years | |
| Kathleen Reape | M | 58 | 1 years | |
| Sailaja Puttagunta | M | 55 | 1 years | |
| Todd Branning | M | 54 | 3 years | |
| Karah Parschauer | F | 46 | 11 years | |
| Karen Ling | F | 60 | 5 years | |
| Alison Hannah | M | 63 | 2 years | |
| Leonard Dove | M | 51 | 2 years | |
| Maria Hilado | F | 59 | 4 years | |
| William Michael Kavanaugh | M | 67 | 5 years | |
| Richard Spivey | M | 74 | 5 years | |
| Melissa Yeager | F | - | 1 years | |
| William Meury | M | 56 | 6 years | |
| Heather Elizabeth Preston | M | 58 | 12 years | |
| Michael Rowe | M | 62 | 6 years | |
| Michael Dunne | M | 64 | 1 years | |
| John W. LaRocca | M | 59 | 1 years | |
| Elisabeth Sandoval | F | 62 | 3 years | |
| Charles M. Mayr | M | 67 | 3 years | |
| Paul Navarre | M | - | - | |
| Eric Lefebvre | M | 60 | 2 years | |
| Tina Devries | M | 63 | 1 years | |
| Eric Carter | M | 72 | 1 years | |
| Laurent Fischer | M | 60 | 4 years | |
| Jonathan Garen | M | 58 | - | |
| Kathryn DiMarco | F | 57 | 5 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 50 | 51.02% |
| Ireland | 44 | 44.90% |
| Canada | 16 | 16.33% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Carlos Campoy
- Personal Network
